STAT Plus: With another trial failure, it may be time to revoke the approval of Acadia Pharma?s anti-psychosis drug
July 23, 2019sandiegobiotechNewsComments Off on STAT Plus: With another trial failure, it may be time to revoke the approval of Acadia Pharma?s anti-psychosis drug
STAT Plus: With another trial failure, it may be time to revoke the approval of Acadia Pharma?s anti-psychosis drug
/
RSS Feed
Share
Link
Embed
With another trial failure, it might be time for the FDA to revoke the approval of Acadia Pharma?s anti-psychosis drug.